Drawing based on the description in the official product monograph. No photo yet.
“The tablets are purplish-pink, capsule-shaped and film-coated, debossed with "GSI" on one side and plain-faced on the other side”
GSI plain-faced pill
Pill with imprint GSI plain-faced is pink, capsule and has been identified as Rilpivirine Hydrochloride and Emtricitabine and Tenofovir Disoproxil Fumarate 25 mg / 200 mg / 300 mg. It is used for HIV. It is supplied by Gilead Sciences Canada Inc.
Sold in Canada
Rilpivirine Hydrochloride and Emtricitabine and Tenofovir Disoproxil Fumarate 25 mg / 200 mg / 300 mg
- Brand
- Complera
- Imprint
- GSI plain-faced
- Strength
- Rilpivirine Hydrochloride 25 mg / Emtricitabine 200 mg / Tenofovir Disoproxil Fumarate 300 mg
- Used for
- HIV
- Color
- Pink
- Shape
- Capsule / oblong
- Form
- Tablet
- Manufacturer
- Gilead Sciences Canada Inc
- Drug class
- HIV medicine
- Sold in
- Canada
- DIN
- 02374129
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
All Emtricitabine and Rilpivirine and Tenofovir Disoproxil pills and guides
What is Emtricitabine and Rilpivirine and Tenofovir Disoproxil used for?
Emtricitabine and Rilpivirine and Tenofovir Disoproxil is used for HIV.
- Medicine type
- HIV medicine
Official uses from the US prescribing label
Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg:
- as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies/mL at the start of therapy or
- to replace a stable antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies/mL) on a stable antiretroviral regimen for at least 6 months with no treatment failure and no known substitutions associated with resistance to the individual components of emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets.
Limitations of Use:
- More rilpivirine-treated subjects with HIV-1 RNA greater than 100,000 copies/mL at the start of therapy experienced virologic failure (HIV-1 RNA ≥ 50 copies/mL) compared to rilpivirine-treated subjects with HIV-1 RNA less than or equal to 100,000 copies/mL.
From the FDA-approved label on DailyMed (published May 30, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows GSI plain-faced. The parts can be split between the two sides, so turn the pill over and check both.
- It is pink, capsule.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Complera by Gilead Sciences Canada Inc.
In Canada: prescription only.
Ingredients
Active: Rilpivirine (Rilpivirine Hydrochloride), Emtricitabine, Tenofovir Disoproxil Fumarate
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G 367
Topiramate 25 mg
Gray & pink, capsule, 14 mm
Used for bipolar disorder and focal seizures
-
V3545
Etoposide 50 mg
Pink, capsule, 8 mm
Used for prostate cancer and urinary bladder neoplasms
-
SD TC 0 5 mg
Tacrolimus 0.5 mg
Orange & pink, capsule, 11 mm
Used for eczema
-
724 par
Hydroxyurea 500 mg
Green & pink, capsule, 19 mm
Used for psoriasis and prostate cancer
-
AMNEAL 584
Temazepam 22.5 mg
Pink & white, capsule, 18 mm
Used for depression and panic disorder
Schedule IV
-
G 580
Fenofibrate 67 mg
Pink, capsule, 14 mm
Used for high cholesterol and high triglycerides